etrials and Omnicare Clinical Research Sign Licensing Agreement
Multi-Year Subscription to Simplify and Accelerate Clinical Trial Research
Morrisville, NC--April 25, 2005--etrials Worldwide, Inc., the first company to offer fully integrated, easy-to-use eClinical software for the clinical trial process, announced today that Omnicare Clinical Research, a subsidiary of Omnicare, Inc. and provider of drug development services to pharmaceutical, biotechnology and medical device companies, has signed a multi-year, subscription licensing agreement that will enable its clients to utilize etrials' eClinical platform for collecting, monitoring and analyzing clinical trial data.
Using these tools, Omnicare will develop and tailor studies for its clients to improve patient enrollment, provide access to cleaner data faster and shorten study timelines. etrials' easy-to-use, fully integrated technologies will help meet the eClinical needs of Omnicare's clients who conduct clinical trials of all sizes and complexities in a wide variety of therapeutic areas. To date, the companies have already begun work on two studies utilizing etrials' eClinical Suite of products.
"Progressive CROs like Omnicare have continued to try and distinguish themselves in the market by seeking out the best new technology offerings for their clients. By offering tools to expedite data collection and ultimately their clients' trials, Omnicare is ahead of the curve," said John Cline, CEO of etrials. "Our first cooperative trial with Omnicare, which is for a top-ten pharmaceutical company, serves as an example that the industry now recognizes the importance of eClinical technologies in trial research."
About etrials Worldwide, Inc.
etrials is a software and services company dedicated to making eClinical easy. We are the first company to offer a fully integrated suite of eClinical software including electronic data capture (EDC), electronic patient reported outcomes (ePRO), interactive voice response (IVR) and analytics to support the entire clinical trial process, from collection and cleaning to the integration and review of data. Our expertise includes studies from Phase I to post-approval for pharmaceutical, biotechnology and clinical research organizations. To date, our team of professionals has participated in over 450 clinical trials in more than 50 different countries.
etrials makes easy-to-use technologies supported by people who are just as easy to work with. Visit us at www.etrials.com.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
